24 completed, 5 recruiting, 3 active not recruiting, 3 not yet recruiting. 16 Phase 3, 11 Phase 4, 10 Phase 2, 1 Not applicable.
Follow RDC Clinical Pty Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRPTI Metabolic and GLP-1 Pharmacodynamic Study TRPTI, Placebo - Overweight , Obesity | Phase 4 | Not yet recruiting | RDC Clinical Pty Ltd | 20 | 2026-10-01 | 2026-09-30 |
| Effects of Macanity on Urinary Health in Males With Lower Urinary Tract Symptoms Maca Root, Placebo - Lower Urinary Tract Symptoms (LUTS) | Phase 2 | Not yet recruiting | RDC Clinical Pty Ltd | 200 | 2026-09-01 | 2026-09-11 |
| Supplementation Absorption Comparison Aquacelle® Omega 3, Comparator Omega 3, Plexosome® Vitamin D3 - Healthy Volunteer | Phase 4 | Recruiting | RDC Clinical Pty Ltd | 160 | 2026-08-31 | 2026-09-10 |
| Vitamin B12 Absorption Study Ampli-B, Vitamin B12 - Healthy Volunteers | Phase 4 | Completed | RDC Clinical Pty Ltd | 12 | 2026-07-20 | 2026-09-09 |
| Gut Microbiome and Metabolic Health Study TRPTI 300mg, Placebo - Healthy Volunteers | Phase 2 | Recruiting | RDC Clinical Pty Ltd | 90 | 2026-07-08 | 2026-07-22 |
| A Novel Cold and Flu Herbal Blend for Reducing the Duration and Severity of the Common Cold Novel Herbal Cold & Flu Blend, Placebo - URTI, Common Cold | Phase 2 | Not yet recruiting | RDC Clinical Pty Ltd | 300 | 2026-07-01 | 2026-06-11 |
| Sleep and Stress Study Lavender Oil, Palmitoylethanolamide (PEA), Oleoylethanolamide - Sleep Disorder (Disorder), Stress | Phase 2 | Recruiting | RDC Clinical Pty Ltd | 240 | 2026-04-07 | 2026-04-23 |
| A Study to See if an Energy Drink With Caffeine and Green Tea Increases Fat Burning When Exercising Active (Green tea and caffeine), Placebo - Exercise | Phase 4 | Active not recruiting | RDC Clinical Pty Ltd | 36 | 2026-03-26 | 2026-09-09 |
| Glucose Tolerance Study TRPTI 150mg, TRPTI 300mg, Placebo - Healthy Volunteers, Glucose Tolerance | Phase 2 | Completed | RDC Clinical Pty Ltd | 19 | 2026-03-11 | 2026-04-28 |
| A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo life'sTM omega O1035DS nTG, life'sTM omega O3020DS nTG, MEG-3 3323rTG - Absorption of Omega-3, Omega-3 Supplementation | Phase 3 | Completed | RDC Clinical Pty Ltd | 120 | 2025-10-27 | 2026-09-09 |
| A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA life's Omega 1035DS, Fish Oil, Placebo - Optimal Absorption of Omega-3, Healthy | Phase 4 | Recruiting | RDC Clinical Pty Ltd | 120 | 2025-08-06 | 2026-09-09 |
| CaroRite™ for Skin Health and Signs of Ageing Carotenoids, Placebo - Healthy Volunteer, Skin Condition | Phase 4 | Completed | RDC Clinical Pty Ltd | 80 | 2025-07-07 | 2026-03-06 |
| Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy Levagen+, Placebo - Diabetic Peripheral Neuropathy | Phase 2 | Recruiting | RDC Clinical Pty Ltd | 80 | 2025-07-01 | 2025-07-23 |
| M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis M-Gard, Placebo - Allergic Rhinitis Due to Grass Pollens | Phase 2 | Completed | RDC Clinical Pty Ltd | 20 | 2025-06-27 | 2026-03-06 |
| LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases LC-Plasma, Placebo - Healthy Volunteer, Immune Response | Phase 3 | Completed | RDC Clinical Pty Ltd | 241 | 2025-04-29 | 2025-11-18 |
| LC-Plasma for Preventing URTIs and Reducing Symptoms LC-Plasma, Placebo - Healthy Volunteer, URTI | Phase 3 | Completed | RDC Clinical Pty Ltd | 637 | 2025-03-28 | 2026-03-06 |
| OEA and LipiSperse Metabolic Study Placebo, 125mg OEA with LipiSperse, 250mg OEA with LipiSperse - Healthy Volunteers - Male and Female, Pharmacokinetic Study in Healthy Volunteers | Phase 4 | Completed | RDC Clinical Pty Ltd | 40 | 2025-03-04 | 2025-11-18 |
| Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population Maolactin, Maltodextrin - Chronic Inflammation, Mobility | Phase 3 | Completed | RDC Clinical Pty Ltd | 97 | 2025-02-27 | 2026-03-06 |
| Long-Term PEA Safety Study Palmitoylethanolamide (PEA), Placebo - Healthy, Safety | Phase 2 | Active not recruiting | RDC Clinical Pty Ltd | 200 | 2025-01-22 | 2026-09-09 |
| Effect of Fenugreek Fibre on Gut Microbiome Fenugreek Fibre - Gut Microbiome | Phase 3 | Withdrawn | RDC Clinical Pty Ltd | 2024-12-01 | 2024-10-21 |
Showing 20 of 36. Sign in to see all of them.
Anemia, Iron-Deficiency (2) · Lower Urinary Tract Symptoms (2) · Myalgia (2) · Anxiety Disorders (1) · Arthralgia (1) · Common Cold (1) · Dermatitis, Atopic (1) · Dysmenorrhea (1) · Erectile Dysfunction (1) · Iron Deficiencies (1) · Migraine Disorders (1) · Motor Activity (1) · Obesity (1) · Overweight (1) · Post-Acute COVID-19 Syndrome (1)
oleoylethanolamide (5) · maltodextrin (4) · microcrystalline cellulose (4) · palmidrol (4) · Fish Oils (2) · locust bean gum (2) · Caffeine (1) · Carotenoids (1) · Cholecalciferol (1) · Docosahexaenoic Acids (1) · Exercise (1) · Grape Seed Extract (1) · Palm Oil (1) · Tea (1) · Vitamin B 12 (1)
Australia (34)
Amanda Rao, PhD (10) · David Briskey, PhD (5) · RV Venkatesh (4) · Anne Birkett (2) · Osamu Kanauchi (2) · Ramasamy Venkatesh (2) · Yusuke Ushida (2) · Alexandros Kanellopoulos (1) · David Briskey (1) · Emily MacNaughton (1) · Maria Cristina Comelli, PhD (1) · Salman Mehkri (1) · Thomas Tompkins (1)